SUBSCRIBE
SUBSCRIBE
News   Business

Karo Pharma: Interim Report January – June 2016

July 15, 2016 | 
1 min read
HUDDINGE, Sweden--(BUSINESS WIRE)--Regulatory News:

Karo Pharma (STO:KARO)

THE PERIOD AND THE SECOND QUARTER

· Net sales amounted to MSEK 165.6 (2.3), whereof the second quarter MSEK 83.3 (1.8)
Earnings Europe
MORE ON THIS TOPIC
Red Businesswoman Silhouette, Black Business People Group Team Concept Vector Illustration
Editorial
GSK CEO Emma Walmsley’s Departure Reseals Pharma’s Glass Ceiling
September 29, 2025
 · 
1 min read
 · 
Annalee Armstrong
GSK CEO Emma Walmsley
C-suite
GSK’s Emma Walmsley, Pharma’s First Woman CEO, Steps Down After 9 Years
September 29, 2025
 · 
4 min read
 · 
Annalee Armstrong
Biogen’s headquarters in Massachusetts
Layoffs
Biogen Shuffles 20 Staff After Ending AAV Work
September 29, 2025
 · 
2 min read
 · 
Tristan Manalac
Creative collage illustration of financial business. Two businessmen shaking hands for partners agreement. Conceptual illustration of success deal, corporate ethic, connection.
Mergers & acquisitions
Genmab Buys Rising Cancer Star Merus for $8B
September 29, 2025
 · 
2 min read
 · 
Tristan Manalac